A new research study on hyperbaric oxygen therapy (HBOT) delivered novel insights on the underlying mechanisms of HBOT and its cognitive benefits in patients with Alzheimer’s disease.
Aging (Aging-US) Research
Sarcopenic patients share clinical features with frailty, but just how similar are they? Researchers used metabolomic analysis to assess the metabolic profiles of sarcopenia in relation to frailty.
Literature on the interaction between cellular senescence and the immune system is reviewed, with a focus on cellular senescence in lymphoid organs.
Data may hold the key to cracking COVID-19. Researchers parsed through clinical data from around the world to glean new insights about this virus’ patterns.
In June 2021, Web of Science (Clarivate Analytics) released their 2020 JCR Impact Factor. Aging is pleased to report that our 2020 impact factor is 5.682.
The MEND (Bredesen) protocol to treat neurodegeneration associated with Alzheimer’s disease was tested in a small cohort. In 2016, researchers followed up with objective results.
In June 2021, Web of Science (Clarivate Analytics) released their 2020 JCR Impact Factor. Aging is pleased to report that our 2020 impact factor is 5.682.
Researchers tested antiviral, anticancer, and immunosuppressive drug combinations that may aid in treating neurodegenerative disorders, including Alzheimer’s disease.
From the University of California Berkeley and Apheresis Care Group, researchers discovered a method of “refreshing” blood that reverses some of the effects of aging.
Authors from the National Institute on Aging wrote the editorial paper, “Mitochondria as extracellular vesicle cargo in aging.”